Thrombopoietin Receptor (TPO)

Avatrombopag is a novel orally-active thrombopoietin (TPO) receptor agonist.

TPO agonist 1 can increase production of platelets by stimulating the TPO receptor in people with chronic ITP.

Lusutrombopag, also known as S-888711, is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist being developed by Shionogi for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery.

Thrombopoietin Human Recombinant, HEK

Thrombopoietin Human Recombinant

Thrombopoietin Mouse Recombinant

ThrombopoietinHuman Recombinant, His Tag